Cerebral vasospasm following aneurysmal subarachnoid hemorrhage (SAH) has devastating consequences. Oxyhemoglobin (oxyhb) has been implicated in SAH-induced cerebral vasospasm as it causes cerebral artery constriction and increases tyrosine kinase activity. Voltage-dependent, Ca 2ϩ -selective and K ϩ -selective ion channels play an important role in the regulation of cerebral artery diameter and represent potential targets of oxyhb. Here we provide novel evidence that oxyhb selectively decreases 4-aminopyridine sensitive, voltage-dependent K ϩ channel (K v ) currents by Ϸ30% in myocytes isolated from rabbit cerebral arteries but did not directly alter the activity of voltage-dependent Ca 2ϩ channels or large conductance Ca 2ϩ -activated (BK) channels. A combination of tyrosine kinase inhibitors (tyrphostin AG1478, tyrphostin A23, tyrphostin A25, genistein) abolished both oxyhb-induced suppression of K v channel currents and oxyhb-induced constriction of isolated cerebral arteries. The K v channel blocker 4-aminopyridine also inhibited oxyhb-induced cerebral artery constriction. The observed oxyhb-induced decrease in K v channel activity could represent either channel block, or a decrease in K v channel density on the plasma membrane. To explore whether oxyhb altered trafficking of K v channels to the plasma membrane, we used an antibody generated against an extracellular epitope of K v 1.5 channels. In the presence of oxyhb, staining of K v 1.5 on the plasma membrane surface was markedly reduced. Furthermore, oxyhb caused a loss of spatial distinction between staining with K v 1.5 and the general anti-phosphotyrosine antibody PY-102. We propose that oxyhb-induced suppression of K v currents occurs via a mechanism involving enhanced tyrosine kinase activity and channel endocytosis. This novel mechanism may contribute to oxyhb-induced cerebral artery constriction following SAH. (Circ Res. 2006;99:1252-1260.) 
V oltage-dependent K ϩ (K v ) channels represent a large family of potassium-selective ion channels characterized by voltage-dependent activation and block by 4-aminopyridine (4-AP). 1 Among their diverse functions, K v channels play an important role in the regulation of cerebral artery diameter both in vitro and in vivo. In isolated cerebral artery myocytes, steady-state 4-AP-sensitive membrane K ϩ currents exist at physiological membrane potentials. 2 Inhibition of K v channels leads to membrane depolarization, increased free intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ), and vasoconstriction attributable to an increase in the open-state probability of voltage-dependent calcium channels (VDCCs). 3, 4 Decreased K v channel activity may contribute to a number of vascular pathologies, including systemic 5, 6 and pulmonary hypertension, 7 diabetes, 8 and subarachnoid hemorrhage (SAH)induced cerebral vasospasm. 4, 9 The reduction of K v channel activity associated with these pathological conditions may reflect decreased channel expression and/or suppression of channel activity.
Activators of protein kinase C (PKC) can decrease K v channel activity in vascular smooth muscle, 10, 11 and enhanced tyrosine kinase activity has been demonstrated to suppress the activity of K v 1 family members in other cell types. 12, 13 The exact mechanisms linking enhanced kinase activity to K v channel suppression in cerebral arteries is unclear. However, a recent report has demonstrated that, in a model system, muscarinic receptor activation leads to K v 1.2 channel suppression by enhanced tyrosine kinase activity and channel internalization via endocytosis. 14 Oxyhemoglobin (oxyhb) causes cerebral artery constriction and is among the blood components contributing to the pathogenesis of cerebral vasospasm following SAH. 15, 16 A number of cellular mechanisms have been reported to contribute to the vasoconstrictor actions of oxyhb and SAH, including increased PKC and tyrosine kinase activity. 16 -20 The objective of the present study was to examine the acute impact of oxyhb on K v currents in freshly isolated cerebral artery myocytes. Here we demonstrate that oxyhb leads to K v channel suppression via a mechanism involving tyrosine kinase, but not PKC activity. Furthermore, we provide novel evidence indicating that oxyhb decreases staining of K v 1.5 channels on the cell surface, consistent with increased channel endocytosis. This mechanism of K v channel suppression may contribute to oxyhb-induced cerebral artery constriction.
Materials and Methods

Tissue Preparation
Posterior cerebral and cerebellar arteries were obtained from healthy New Zealand White rabbits (males, 3.0 to 3.5 kg, Charles River Laboratories, Saint Constant, Quebec, Canada) as described previously. 21 In 1 experimental series, cerebral arteries were also obtained from an established rabbit model of SAH 21,22 5 days following intracisternal injection of 3 mL of whole blood. All procedures and protocols were conducted in accordance with the guidelines for the care and use of laboratory animals (NIH publication 85- 23, 1985) and followed protocols approved by the Institutional Animal Use and Care Committee of the University of Vermont. Human cerebral arteries, removed as a necessary part of a required procedure, were obtained from 1 consenting surgical patient. The University of Vermont has an approved assurance of compliance with the Department of Health and Human Services covering this activity (Assurance Identification no. FWA723; Institutional Review Board identification no. 0485).
Measurements of Arterial Diameter
Cerebral artery segments were cannulated on glass pipettes mounted in a 5-mL myograph chamber (Living Systems Instruments, Burlington, Vt), as previously described. 22, 23 Arteries were discarded if an initial constriction representing less than a 50% decrease in diameter was observed when arteries were exposed to elevated extracellular K ϩ (60 mmol/L).
Measurements of K v and VDCC Currents
Vascular smooth muscle cells were enzymatically isolated from cerebral arteries 24 and the perforated-patch configuration of the patch-clamp technique was used to measure voltage-dependent K ϩ (K v ) currents. 6 The external (bath) solution contained (in mmol/L): 135 NaCl, 5.4 KCl, 1.8 CaCl 2 , 10 HEPES, 1 MgCl 2 , 5.2 glucose (pHϭ7.4). Patch pipettes (3 to 5 M⍀) were filled with an internal solution that contained (in mmol/L): 110 potassium aspartate, 30 KCl, 10 NaCl, 1 MgCl 2 , 0.05 EGTA, 10 HEPES with 200 mol/L amphotericin B (pHϭ7.2). Whole-cell VDCC currents were measured using the conventional whole-cell configuration of the patchclamp technique. 21 The external (bath) solution contained (in mmol/ L): 125 NaCl, 10 BaCl 2 , 5 KCl, 10 HEPES, 1 MgCl 2 , 10 glucose (pHϭ7.4). Patch pipettes for VDCC measurements contained (in mmol/L): 130 CsCl, 10 ethylene glycol-bis(␤-aminoethyl ether)-N,N,NЈ,NЈ-tetraacetic acid, 10 HEPES, 1 MgCl 2 , 2 ATP, 0.5 GTP, 5 phosphocreatine, 10 glucose (pHϭ7.2). Measurements were obtained from cells before, and following, 10 minutes of exposure to purified oxyhb A 0 (provided by Hemosol Inc, Toronto, Canada).
Immunofluorescent Detection of Surface K v 1.5
Freshly dissociated cerebral artery myocytes were incubated at 37°C either in the presence or absence of oxyhb for 10 minutes then fixed with 4% formaldehyde. Cells were washed, then incubated with a rabbit polyclonal anti-K v 1.5 antibody (1:200 dilution) generated against an epitope in the second extracellular loop of the ␣ subunit of the channel (a gift from Dr James Trimmer, University of California, Davis), and labeled with Alexa 568/goat anti-rabbit (Alexa 568-GAR) (1:500). This method produces staining of the channel on or near the cell surface and does not appear to stain intracellular channels. For cells costained with anti-phosphotyrosine antibody, surface K v 1.5 primary antibody was applied as described above; subsequently, cells were permeabilized with ice-cold acetone for 4 minutes, washed, blocked with PBSϩ3% goat serum for 20 minutes at 37°C, stained with the general anti-phosphotyrosine antibody PY-102 (1:200), and subsequently labeled with Alexa 568-GAR (1:500) and Alexa 647/goat anti-mouse (Alexa 647-GAM) (1:500). F-Actin was visualized using Alexa 488-phalloidin (1:200). Six to 10 cells were averaged from each animal (n).
Statistical Analysis
Data are presented as meanϮSEM. Statistical significance was considered at the level of PϽ0.05 (*) or PϽ0.01 (**) using Student's t test.
Results
Oxyhb Constricts Small-Diameter Cerebral Arteries From Healthy Rabbits
Our initial goal was to examine the direct impact of oxyhb on small-diameter cerebral arteries. Cerebral arteries 100 to 200 m in diameter constrict in response to elevations in intravascular pressure, a phenomenon critical in the autoregulation of blood flow to the brain. We observed that increasing intravascular pressure from 10 to 60 mm Hg constricted isolated rabbit cerebral arteries by 36.2Ϯ12.2 m (nϭ6), representing an approximate 16% decrease in diameter. Purified oxyhb (10 mol/L) caused an additional constriction in these arteries of 28.2Ϯ6.7 m (nϭ6) (Figure 1a and 1b). The constriction caused by oxyhb reached a maximum within 5 minutes and was sustained for the duration of the oxyhb application.
VDCCs play an important role in the regulation of cerebral artery diameter and L-type calcium channel antagonists, such as diltiazem, are potent vasodilators of these arteries ( Figure  1a and 1b). To examine whether oxyhb directly enhances VDCC activity, the whole-cell patch-clamp technique, with 10 mmol/L Ba 2ϩ as the charge carrier, was used to measure VDCC currents in freshly isolated rabbit cerebral artery myocytes. From a holding potential of Ϫ80 mV, depolarizing voltage steps to ϩ20 mV elicited inward membrane currents characteristic of VDCCs. 21 Oxyhb (10 mol/L or 100 mol/L for 10 minutes) did not alter VDCC currents in cerebral artery myocytes isolated from healthy animals (Figure 1c and 1d ). These data demonstrate that Ca 2ϩ influx via VDCCs may be involved in oxyhb-induced cerebral artery constriction; however, oxyhb does not directly alter their open-state probability.
Oxyhb Decreases K v Currents in Rabbit and Human Cerebral Artery Myocytes
As cerebral artery constriction requires Ca 2ϩ entry through VDCCs, we next examined whether oxyhb indirectly increases VDCC activity via membrane potential depolarization through inhibition of K ϩ channels. Using the perforated patch-clamp technique, outward membrane K ϩ currents were elicited by a series of 10-mV depolarizing steps (to ϩ50 mV) from a holding potential of Ϫ80 mV ( Figure 2 ). Oxyhb (30 mol/L) markedly decreased outward K v currents in freshly isolated rabbit cerebral artery myocytes (Figure 2a and 2c). At ϩ40 mV, oxyhb decreased outward K ϩ channel current density by approximately 40%. Although oxyhb reduced K v currents, the activation time constants for these currents were similar in the absence (ϩ40 mV, ϭ56.4Ϯ6.8 ms; nϭ11) and presence of oxyhb (ϩ40 mV, ϭ54.2Ϯ5.0 ms; nϭ11).
Few studies have examined K ϩ channel function in the human cerebral vasculature. We therefore also examined the ability of oxyhb to influence K v currents in small-diameter human cerebral arteries obtained from a consenting surgical patient. At ϩ40 mV, the K ϩ channel current density was 16.5Ϯ6.9 pA/pF (nϭ3 cells from 1 individual), compared with the current density of 27.9Ϯ3.4 pA/pF observed in rabbit cerebral myocytes using similar recording conditions. Oxyhb reduced currents in human cerebral artery myocytes by approximately 40% (Figure 2b and 2d ), a decrease similar to that observed in the rabbit.
Oxyhb Decreases K v , but Not BK, Currents in Rabbit Cerebral Artery Myocytes
In cerebral artery myocytes, K ϩ currents evoked by membrane depolarization reflect the combined activity of largeconductance Ca 2ϩ -activated (BK) channels and delayed rectifier (K v ) channels. A hallmark of K v channels is their block by 4-aminopyridine (4-AP). 1 4-AP (10 mmol/L) reduced outward K ϩ currents in rabbit cerebral artery myocytes by 35% to 45% at membrane potentials between ϩ10 and ϩ50 mV ( Figure 3 ). Following inhibition of K v currents by 4-AP, oxyhb no longer reduced outward K ϩ currents (Figure 3a , 3b, and 3e), consistent with a suppression of K v currents by oxyhb. For example, at ϩ40 mV, K ϩ channel current density was reduced from 24.0Ϯ2.8 to 15.4Ϯ1.9 pA/pF by 4-AP, with no further reduction by oxyhb (13.9Ϯ0.8 pA/pF in the presence of 4-AP and oxyhb). Additionally, we used iberio-toxin (IBTX) (100 nmol/L), a selective blocker of BK channels, to examine whether oxyhb could also alter voltagedependent BK channel activity. Consistent with a contribution of BK channels to outward K ϩ currents, IBTX decreased whole-cell K ϩ currents by approximately 40% at ϩ40 mV. However, oxyhb still reduced outward K ϩ channel current density in the presence of IBTX (Figure 3c , 3d, and 3f). Furthermore, IBTX-sensitive BK current density at ϩ40 mV was not significantly different in the absence (11.3Ϯ1.3 pA/pF) and presence (9.0Ϯ0.4 pA/pF) of oxyhb. These data demonstrate that oxyhb decreases the amplitude of K v , but not BK, currents evoked by membrane potential depolarization in cerebral artery myocytes isolated from healthy rabbits. Functional studies examining diameter changes in isolated pressurized cerebral arteries were in accord with the actions of 4-AP and IBTX on K ϩ channel current densities ( Figure 3e ). Both IBTX and 4-AP constricted pressurized cerebral arteries, demonstrating the functional presence of BK and K v channels. Consistent with our electrophysiological data, inhibition of K v channels with 4-AP abolished oxyhb-induced cerebral artery constriction. However, oxyhb-induced constriction was still observed following inhibition of BK channels with IBTX. These data are consistent with oxyhbinduced K v channel inhibition leading to cerebral artery constriction. In the presence of 4-AP, increasing extracellular K ϩ to 60 mmol/L caused an additional constriction (76Ϯ2% decrease in diameter; nϭ5), ensuring that 4-AP was not causing a maximal constriction in this tissue.
Oxyhb-Induced Suppression of K v Currents: Involvement of Tyrosine Kinase Activity
We next sought to explore potential cell signaling pathways linking oxyhb to decreased K v channel current density in freshly isolated cerebral artery myocytes. Activation of protein tyrosine kinases (PTKs) leads to suppression of K v Figure 1 . Oxyhb constricts smalldiameter cerebral arteries but does not directly influence VDCC activity. a, Diameter recording from an isolated rabbit cerebral artery pressurized to 60 mm Hg. Oxyhb (10 mol/L) constricted, and the L-type Ca 2ϩ channel blocker antagonist diltiazem (50 mol/L) dilated this artery. Removal of extracellular Ca 2ϩ (0 Ca 2ϩ ) did not significantly dilate the artery in the presence of diltiazem. b, Summary of oxyhb-induced constriction of isolated rabbit cerebral arteries (nϭ5). *PϽ0.05 vs diameter in the absence of oxyhb. c, VDCC current recordings from a rabbit cerebral artery myocyte. Voltage steps were from a holding potential of Ϫ80 to ϩ20 mV using the conventional wholecell patch-clamp technique with 10 mmol/L Ba 2ϩ as a charge carrier. Tracings represent the average of 6 and 14 voltage steps from a single cell in the absence and presence of oxyhb, respectively. d, Averaged peak membrane currents before and 10 minutes after addition of oxyhb (100 mol/L) (nϭ4).
currents in nonvascular cultured cells. [12] [13] [14] To examine the involvement of PTKs in oxyhb-induced suppression of K v currents in cerebral artery myocytes, we used a combination of PTK inhibitors including tyrphostin AG1478 (2.5 mol/ L), tyrphostin A23 (2.5 mol/L), tyrphostin A25 (2.5 mol/ L), and genistein (15 mol/L). This combination of PTK inhibitors abolished oxyhb-induced K v current suppression (Figure 4a and 4b) . Furthermore, PTK inhibitors abolished oxyhb-induced constriction of isolated pressurized cerebral arteries, whereas K ϩ -induced constriction was unaltered (Figure 4c) .
Previous work by others has demonstrated that PKC can reduce K v channel activity in vascular smooth muscle 10, 11 and enhanced activity of several PKC isoforms, including PKC␣, -␦, and -, can occur during oxyhb exposure or following SAH. 16, 20 However, we found that chelerythrine (1 mol/L), an inhibitor of PKC isoforms ␣, ␤ 1 , ␤ 2 , ␥, and ␦ and GF109203X (1 mol/L), an inhibitor of PKC isoforms , , and , did not impact the ability of oxyhb to suppress K ϩ currents (Figure 4d ). However, both chelerythrine and GF109203X were effective in blunting K v current suppres-sion caused by the PKC activator 1,2-dioctanoyl-sn-glycerol (DOG) (1 mol/L) (M. Koide and G.C.W., unpublished observations, 2006). These data suggest activity of PTKs, but not PKC, is involved in the inhibition of K v channels by oxyhb in cerebral myocytes.
Oxyhb-Induced Decreased Surface K v 1.5 Channel Staining Involves Tyrosine Kinase Activity
Oxyhb-induced PTK activity could suppress K v currents through a reduction in channel open probability or through a decrease in channel number on the plasma membrane. The kinetic properties of the 4-AP and oxyhb-sensitive K ϩ currents seemed similar, suggesting that channel number may be reduced. K v 1.5 is expressed in cerebral arteries 25, 26 and has been shown to undergo PTK-dependent phosphorylation in other cell types. 27 In the absence of oxyhb, application of an antibody directed against an extracellular epitope of K v 1.5 to formaldehyde-fixed myocytes revealed staining for surface K v 1.5 within large but defined regions on the cell surface ( Figure 5 ). Costaining of control cells with an antiphosphotyrosine antibody (PY102) revealed phosphotyrosine Figure 2 . Oxyhb decreases membrane K ϩ currents in rabbit and human cerebral artery myocytes. a, Outward K ϩ currents elicited by a series of 10-mV depolarizing steps to ϩ50 mV from a holding potential of Ϫ70 mV in the absence (left) and presence (right) of oxyhb (30 mol/L). Currents were obtained using the perforated patch configuration of the patchclamp technique (intracellular K ϩ , 140 mmol/L; extracellular K ϩ , 5.4 mmol/ L). b, Outward K ϩ currents from a freshly isolated human cerebral artery myocyte. c, Summary of the steady-state current/ voltage relationship of voltagedependent K ϩ channel currents obtained from rabbit cerebral artery myocytes (nϭ5). Current density was calculated by dividing membrane current by cell capacitance for each cell. *PϽ0.05, **PϽ0.01. d, Summary of the steadystate current/voltage relationship of voltage-dependent K ϩ channel currents obtained from human cerebral artery myocytes (nϭ3). rich vesicular compartments adjacent to the plasma membrane (see Figure 5 , z-projection; and the online movie supplement, available at http://circres.ahajournals.org). Oxyhb elicited a redistribution of K v 1.5 into smaller, sharply defined foci ( Figure 5 ). Reconstruction of a z-axis micrograph series suggests fusion of the phosphotyrosine-enriched vesicles with the surface K v 1.5 density (see Figure 5 , z-projection; and online movie supplement). The above observations are consistent with oxyhb causing enhanced tyrosine kinase activity and tyrosine phosphorylation of K v 1.5, or a closely associated protein. In an attempt to strengthen these findings, efforts were made using Western blot to detect oxyhb-induced tyrosine phosphorylation of K v 1.5. However, using a variety of available antibodies generated against K v 1.5, or anti-phosphotyrosine residues, we were unable to immunoprecipitate sufficient quantities of the desired substrate to allow western blot detection of the phosphorylated protein. A number of factors, including inefficient detection of the specific rabbit epitope with available antibodies, comparatively low levels of K v 1.5 expression combined with a relatively small amount of total phosphorylated protein obtained from these 100 to 200 m diameter cerebral arteries, or loss of phosphorylation by an associated phosphatase, may have contributed to our lack of success with this experimental series.
Using immunofluorescence, we did observe that oxyhb caused a significant reduction in the total amount of K v 1.5 detectable on the cell surface (Figure 6a ), suggesting that oxyhb may elicit trafficking of K v 1.5 from the cell surface. Oxyhb did not change total F-actin staining, but did slightly reduce the average pixel area occupied by each cell, consistent with oxyhb-induced cell contraction. The oxyhb-induced decrease in surface staining of K v 1.5 was abolished by a combination of PTK inhibitors (Figure 6b ). Collectively, these findings are consistent with the hypothesis that K v 1.5 suppression involves tyrosine phosphorylation-dependent trafficking of the channel from the cell surface.
Oxyhb Does Not Suppress K v Channel Activity in Cerebral Artery Myocytes Following SAH
Oxyhb is among the blood components contributing to SAH-induced cerebral vasospasm, 15, 16, 28 and previous work by others suggests altered K v function following SAH. 4, 9 We next examined the ability of oxyhb to suppress K v channel Figure 3 . Oxyhb decreases K v , but not BK, currents in rabbit cerebral artery myocytes. a and b, Outward membrane currents from a cell exposed to the K v channel blocker 4-AP (10 mmol/L) were similar in the absence (a) and presence (b) of oxyhb (30 mol/L). c and d, Outward membrane currents from a cell exposed to the BK channel blocker IBTX (100 nmol/L). Currents were greater in the absence (c) than in the presence (d) of oxyhb (30 mol/L). e, Summary of membrane currents in 5 cells exposed to 4-AP, then subsequently exposed to a combination of 4-AP and oxyhb. Control represents the initial currents obtained in the absence of 4-AP. f, Summary of membrane currents in 5 cells exposed to IBTX, then subsequently exposed to a combination of IBTX and oxyhb. g, Summary of IBTX-and 4-AP-induced constriction of isolated cerebral arteries pressurized to 60 mm Hg. In the absence of oxyhb, both IBTX-and 4-AP-constricted arteries, demonstrating the functional presence of BK and K v channels. Oxyhb-induced constriction was still observed following inhibition of BK channels with IBTX. However, inhibition of K v channels with 4-AP abolished oxyhb-induced constriction. *PϽ0.05, **PϽ0.01. activity and constrict small-diameter cerebral arteries following experimental SAH. If oxyhb-induced K v suppression occurs during SAH, we would predict that exogenous oxyhb would have little additional effect on arteries from SAH animals. Cerebral arteries were obtained from a rabbit SAH model 5 days after the intracisternal injection of whole blood. In the absence of exogenous oxyhb, K ϩ current density from SAH animals was reduced by approximately 30% compared with that of myocytes from control animals (Figure 7) . Thus, the K ϩ channel current density in myocytes from SAH animals was similar to myocytes from healthy animals following acute exposure to oxyhb. Acute application of oxyhb failed to further suppress K v currents in myocytes from SAH animals (Figure 7a and 7b) . Based on the inability of oxyhb to suppress K v currents following SAH, we hypothesized that oxyhb-induced constriction would be impaired in cerebral arteries from SAH animals. Consistent with this hypothesis, oxyhb did not constrict cerebral arteries from SAH animals in vitro (Figure 7c and 7d ). As we have reported previously, 21 in the absence of exogenous oxyhb, arteries from SAH animals exhibit enhanced pressure-induced constrictions that are abolished by the combination of an L-type VDCC blocker, diltiazem, and an R-type VDCC blocker, SNX-482. These findings suggest that oxyhb-induced K v channel suppression may contribute to the complex series of events leading to enhanced cerebral artery constriction following SAH. . Tyrosine kinase inhibitors abolish oxyhb-induced suppression of K ϩ currents in rabbit cerebral artery myocytes. a and b, Voltage-dependent K ϩ currents from a cell exposed to tyrosine kinase inhibitors were similar in the absence (a) and presence (b) of oxyhb (30 mol/L). The tyrosine kinase inhibitors included the following: tyrphostin AG1478 (2.5 mol/L), tyrphostin A23 (2.5 mol/L), tyrphostin A25 (2.5 mol/L), and genistein (15 mol/L). c, Summary of diameter measurements from 4 arteries exposed to tyrosine kinase inhibitors, then subsequently to oxyhb. Oxyhb-induced constrictions were abolished in arteries treated with tyrosine kinase inhibitors; however, arteries still exhibited robust constrictions to elevated extracellular K ϩ . d, Suppression K ϩ current density at ϩ40 mV by oxyhb in the presence of chelerythrine (1 mol/L, nϭ4), GF109203X (1 mol/L, nϭ5), or the combination of tyrosine kinase inhibitors described above. **PϽ0.01 vs cells treated with tyrosine kinase inhibitors in the absence of oxyhb. Figure 5 . Oxyhb leads to loss of spatial distinction between K v 1.5 and phosphotyrosine-enriched compartments within arterial myocytes. a, Surface K v 1.5 in control cells detected by application of an antibody directed against an epitope within the second extracellular loop of the channel (K v 1.5) (top). Subsequent application of a monoclonal antibody directed against phosphotyrosine revealed colocalization of K v 1.5 with phosphotyrosine-enriched regions (PY102 and merge) (middle panels). Each panel represents an approximately 2-m optical slice through a z-section taken near the surface of the cell and resolved using reconstructive fluorescence microscopy. b, Application of oxyhb (10 mol/L, 10 minutes) produced a striking redistribution of both the K v 1.5 and the phosphotyrosine signal to small, sharply defined foci. A projection of a 3D reconstruction of an optical z-series taken through the entire cell (z-projection) revealed that in control cells the phosphotyrosine signal appears as vesicles lying adjacent to but not in contact with the plasma membrane. In contrast, a similar optical reconstruction reveals that the phosphotyrosine and K v 1.5 signals appear fused at the plasma membrane after treatment with oxyhb. Also, see the online movie supplement.
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Discussion
In this study, we provide the first evidence indicating K v channel suppression contributes to oxyhb-induced cerebral artery constriction. Furthermore, our data suggest that oxyhbinduced K v channel suppression occurs via enhanced tyrosine kinase activity and a decrease in functional channels on the plasma membrane. The following observations are consistent with this novel action of oxyhb: (1) oxyhb-induced cerebral artery constriction is abolished by block of K v channels or tyrosine kinase inhibition; (2) oxyhb suppresses K v current density, but does not directly alter BK channel or L-type VDCC current density; (3) oxyhb decreases staining of K v 1.5 on the plasma membrane; and (4) inhibitors of protein tyrosine kinases abolish both the ability of oxyhb to suppress K v currents and decrease K v 1.5 surface staining. We also observed oxyhb-induced suppression of K v currents in the human cerebral vasculature. In cerebral artery myocytes, K v current suppression would lead to membrane potential depolarization, an increase in the open-state probability of VDCCs, enhanced Ca 2ϩ influx and ultimately, vasoconstriction.
Recent studies have revealed that in vascular myocytes, functional K v channels likely represent heterotetramers of 2 K v family members, K v 1.2 and K v 1.5. 26, 29, 30 In arterial myocytes, mRNA levels of K v 1.5 are the most abundant of known K v family members. 25, 31 Using an antibody generated against an extracellular epitope of K v 1.5, we observed that oxyhb caused a marked decrease in K v 1.5 staining on the surface of nonpermeabilized cells. A recent study by Choi et al 32 found that disruption of the endocytotic machinery leads to increased K v 1.5 currents and a corresponding increase in surface expression of this channel, whereas Nesti et al 14 have found tyrosine kinase activity promoted suppression of K v 1.2 current via increased channel endocytosis. Thus, although our present study does not directly demonstrate oxyhb enhances K v 1.5 channel endocytosis, our observations are consistent with recent reports demonstrating that endocytotic activity can regulate K v currents on the plasma membrane.
In the present study, we also provide 2 lines of evidence that enhanced tyrosine kinase activity is involved in oxyhbinduced suppression of K v currents. Firstly, pharmacological inhibition of tyrosine kinases blocked the ability of oxyhb to suppress K v current density (Figure 4 ) and abolished both oxyhb-induced decreased surface K v 1.5 staining ( Figure 6 ) and cerebral artery constriction (Figure 4) . Secondly, staining with a general anti-phosphotyrosine antibody revealed that oxyhb caused colocalization of phosphotyrosine and K v 1.5 signals ( Figure 5 ). Although the identity of the specific tyrosine kinase linked to oxyhb-induced suppression of K v 1.5 remains to be determined, other investigators have demonstrated that Src kinase can bind to and phosphorylate K v 1.5. 27 It is also possible that oxyhb could increase the activity of receptor-mediated tyrosine kinases such as the EGF receptor, which has been implicated in the suppression of K v 1.2 membrane currents. 33 Although it is likely that K v 1.5 is a direct target for tyrosine phosphorylation, it is conceivable that phosphorylation of other K v 1 subunits within the channel or a closely associated protein may also play a role in the loss of surface channel.
The present work also suggests that oxyhb-induced suppression of K v channels may contribute to the vascular pathology of cerebral vasospasm following aneurysm rupture and SAH. We found K v currents were decreased in myocytes obtained from a rabbit SAH model and that the effects of SAH and acute exposure of oxyhb were not additive. Our data are consistent with previous reports suggesting K v channel activity is decreased following SAH 4,34 and provides the first evidence implicating oxyhb in this phenomenon. Alternatively, it is possible that the suppression of K ϩ currents following SAH represent a decrease in K ϩ channel expression, or altered expression of a signaling protein involved in the action of oxyhb on K v channels. Additional studies are required to firmly establish the mechanism of decreased K ϩ channel activity following SAH.
In summary, this work demonstrates that oxyhb-induced suppression of K v currents in cerebral artery myocytes occurs via tyrosine kinase-dependent reduction of K v 1.5 channels on the plasma membrane. This novel mechanism contributing to cerebral artery constriction may represent a more widespread mechanism whereby endogenous vasoactive substances modulate cerebral artery function. Furthermore, oxyhb-induced suppression of K v currents may contribute to decreased cerebral blood flow and the accompanying neurological deficits associated with SAH. Figure 7 . Oxyhb does not suppress K v channel activity in cerebral artery myocytes following SAH. a, Voltagedependent K ϩ currents from a cerebral myocyte isolated from a SAH rabbit 5 days after intracisternal injection of whole blood. Currents were obtained in the absence (left) and presence (right) of purified oxyhb. b, Summary of current/voltage relationship of K ϩ currents obtained from SAH myocytes in the presence and absence of oxyhb (nϭ6). c, Diameter recording from a cerebral artery isolated from a SAH rabbit pressurized to 60 mm Hg. Oxyhb (10 mol/L) did not constrict this artery. The L-type Ca 2ϩ channel blocker diltiazem (50 mol/L) caused an approximate 80% dilation of the pressure-induced constriction, with the remaining pressure-induced constriction reversed by the R-type Ca 2ϩ channel blocker SNX-482 (200 nmol/L). Removal of extracellular Ca 2ϩ (0 Ca 2ϩ ) caused no further dilation. d, Summary of oxyhb-induced constriction of cerebral arteries from healthy (control, nϭ5) and SAH (nϭ4) rabbits. Constrictions are presented as a percentage decrease in arterial diameter in arteries pressurized to 60 mm Hg. **PϽ0.05.
